Pregnancy failure in patients with obstetric antiphospholipid syndrome with conventional treatment: The influence of a triple positive antibody profile

Lupus

Volumn 26, Issue 9, 2017, Pages 983-988

  Latino, J O ^a   Udry, S ^a,b   Aranda, F M ^b   Peres Wingeyer S D A ^b   Fernandez Romero D S ^a   De Larranaga G F ^b  

^a HOSPITAL DURAND   (Argentina)

^b HOSPITAL F J MUÑIZ   (Argentina)

Author keywords

anticardiolipin antibodies; Antiphospholipid syndrome; Hughes syndrome; pregnancy; thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; CITRIC ACID; HEPARIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; BETA2 GLYCOPROTEIN 1; PHOSPHOLIPID ANTIBODY;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; AUTOIMMUNE DISEASE; FEMALE; FETUS GROWTH; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANCY DISORDER; PREGNANCY OUTCOME; PREGNANCY TERMINATION; PREMATURITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS; ARGENTINA; BLOOD; COMPLICATION; IMMUNOLOGY; PREGNANCY; SPONTANEOUS ABORTION; TREATMENT FAILURE;

ABORTION, SPONTANEOUS; ADULT; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; ARGENTINA; ASPIRIN; AUTOIMMUNE DISEASES; BETA 2-GLYCOPROTEIN I; FEMALE; HEPARIN; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES; RISK FACTORS; THROMBOSIS; TREATMENT FAILURE;

EID: 85023198961     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203317692432     Document Type: Article

References (27)

1. Kutteh WH,. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 1996; 174: 1584-1589.
2. Rai R, Cohen H, Dave M, et al. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 1997; 314: 253-257.
3. Franklin RD, Kutteh WH,. Antiphospholipid antibodies (APA) and recurrent pregnancy loss: treating a unique APA positive population. Hum Reprod 2002; 17: 2981-2985.
4. Mak A, Cheung MW, Cheak AA, et al. Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression. Rheumatology (Oxford) 2010; 49: 281-288.
5. Empson M, Lassere M, Craig JC, et al. Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials. Obstet Gynecol 2002; 99: 135-144.
6. Ruffatti A, Tonello M, Visentin MS, et al. Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study. Rheumatology (Oxford) 2011; 50: 1684-1689.
7. Bramham K, Thomas M, Nelson-Piercy C, et al. First-trimester low-dose prednisolone in refractory antiphospholipid antibody-related pregnancy loss. Blood 2011; 117: 6948-6951.
8. Danowski A, de Azevedo MN, de Souza Papi JA, et al. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus. J Rheumatol 2009; 36: 1195-1199.
9. Carmona F, Font J, Azulay M, et al. Risk factors associated with fetal losses in treated antiphospholipid syndrome pregnancies: a multivariate analysis. Am J Reprod Immunol 2001; 46: 274-279.
10. Simchen MJ, Dulitzki M, Rofe G, et al. High positive antibody titers and adverse pregnancy outcome in women with antiphospholipid syndrome. Acta Obstet Gynecol Scand 2011; 90: 1428-1433.
11. Jeremic K, Stefanovic A, Dotlic J, et al. Neonatal outcome in pregnant patients with antiphospholipid syndrome. J Perinat Med 2015; 43: 761-768.
12. De Carolis S, Botta A, Santucci S, et al. Predictors of pregnancy outcome in antiphospholipid syndrome: a review. Clin Rev Allergy Immunol 2010; 38: 116-124.
13. De Carolis S, Santucci S, Botta A, et al. The relationship between TORCH complex false positivity and obstetric outcome in patients with antiphospholipid syndrome. Lupus 2012; 21: 773-775.
14. Ruffatti A, Tonello M, Cavazzana A, et al. Laboratory classification categories and pregnancy outcome in patients with primary antiphospholipid syndrome prescribed antithrombotic therapy. Thromb Res 2009; 123: 482-487.
15. Ruffatti A, Calligaro A, Hoxha A, et al. Laboratory and clinical features of pregnant women with antiphospholipid syndrome and neonatal outcome. Arthritis Care Res (Hoboken) 2010; 62: 302-307.
16. Ruffatti A, Calligaro A, Del Ross T, et al. Risk-based secondary prevention of obstetric antiphospholipid syndrome. Lupus 2012; 21: 741-743.
17. Ruffatti A, Salvan E, Del Ross T, et al. Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positivity. A European multicentre retrospective study. Thromb Haemostasis 2014; 112: 727-735.
18. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemostasis 2006; 4: 295-306.
19. Catelli ML, Alvarez-Iglesias V, Gomez-Carballa A, et al. The impact of modern migrations on present-day multi-ethnic Argentina as recorded on the mitochondrial DNA genome. BMC Genet 2011; 12: 77-77.
20. Corach D, Lao O, Bobillo C, et al. Inferring continental ancestry of argentineans from Autosomal, Y-chromosomal and mitochondrial DNA. Ann Hum Genet 2010; 74: 65-76.
21. De Larranaga GF, Forastiero RR, Carreras LO, et al. Different types of antiphospholipid antibodies in AIDS: a comparison with syphilis and the antiphospholipid syndrome. Thromb Res 1999; 96: 19-25.
22. Erkan D, Patel S, Nuzzo M, et al. Management of the controversial aspects of the antiphospholipid syndrome pregnancies: a guide for clinicians and researchers. Rheumatology (Oxford) 2008; 47 (Suppl 3): iii23-iii27.
23. Forastiero R, Martinuzzo M,. The emerging role of multiple antiphospholipid antibodies positivity in patients with antiphospholipid syndrome. Expert Rev Clin Immunol 2015; 11: 1255-1263.
24. Pengo V, Banzato A, Bison E, et al. Antiphospholipid syndrome: critical analysis of the diagnostic path. Lupus 2010; 19: 428-431.
25. Banzato A, Pozzi N, Frasson R, et al. Antibodies to Domain I of beta(2)Glycoprotein I are in close relation to patients risk categories in Antiphospholipid Syndrome (APS). Thromb Res 2011; 128: 583-586.
26. De Laat B, Derksen RH, Urbanus RT, et al. IgG antibodies that recognize epitope Gly40-Arg43 in domain I of beta 2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis. Blood 2005; 105: 1540-1545.
27. Pengo V, Ruffatti A, Tonello M, et al. Antibodies to Domain 4/5 (Dm4/5) of beta2-Glycoprotein 1 (beta2GP1) in different antiphospholipid (aPL) antibody profiles. Thromb Res 2015; 136: 161-163.